The study, published in Acta Parasitologica by Damian Pikor, Maciej Cymerys and Małgorzata Paul of Poznan University of Medical Sciences, examined 48 adults hospitalized with microscopically confirmed imported falciparum malaria between 2010 and 2025 at a tertiary referral centre for tropical infections. All patients carried a single Plasmodium species, excluding mixed infections that might confound the picture, and all laboratory values were drawn from the first admission measurements before any antimalarial therapy was given. The cohort was predominantly male, at 72.9 percent, with a median age of 43.5 years, and patients had acquired their infections across 20 countries, almost exclusively in sub-Saharan Africa, with Cameroon, Nigeria and Guinea the most frequent sources of exposure.

The clinical picture at admission was dominated by hematological and inflammatory derangement. Thrombocytopenia, defined as a platelet count below 150,000 per microliter, was present in 85.4 percent of patients, and nearly a third had severe thrombocytopenia with counts below 50,000. Alanine aminotransferase exceeded 56 units per liter in 41.7 percent of the cohort, while creatinine surpassed 1.5 milligrams per deciliter in only 10.4 percent. These thresholds, the authors stress, are descriptive biochemical markers rather than diagnostic criteria for organ failure, a distinction that matters because a single admission creatinine cannot establish acute kidney injury without knowledge of baseline values or urine output.

The analytical heart of the study is the precision matrix, a tool that has found traction in metabolomics and behavioral science but remains rare in clinical parasitology. The researchers rank-transformed eight variables, seven laboratory measurements plus age, computed the Spearman correlation matrix, and then inverted it. The inverse yields partial correlations: pairwise associations between two variables after controlling for the six remaining ones. Of the 28 possible pairs, each adjusted for all others, only three survived the stringent Bonferroni correction, which set the significance threshold at approximately 0.0018. The three survivors were strikingly coherent. Alanine aminotransferase moved with aspartate aminotransferase at a partial correlation of plus 0.88, a near-lockstep relationship between the two liver enzymes. Hemoglobin tracked red blood cell count at plus 0.82, an almost tautological pairing of two measures of the same erythron. And C-reactive protein was inversely associated with platelet count at minus 0.56, meaning that the more intense the inflammatory response, the lower the platelets fell, independent of liver enzymes, renal markers, hemoglobin or age.

That third association is the most biologically provocative. Thrombocytopenia in malaria has been attributed to many mechanisms: platelets binding to infected erythrocytes, splenic clearance, immune-mediated destruction, and consumption in the coagulation cascade. Human studies have documented that platelets can actually kill intraerythrocytic parasites, suggesting an active host defense role rather than passive depletion. The new findings do not adjudicate among these mechanisms, and the authors are explicit on this point. The analysis measured neither platelet activation nor complement deposition, cytokines or endothelial biomarkers, so it cannot assign platelet loss to any specific inflammatory pathway. What it does establish is that the CRP-platelet relationship is not an artifact of other concurrent laboratory abnormalities; it persists when the rest of the admission panel is held statistically constant.

Equally informative is what disappeared. In exploratory subset analyses, the associations between platelet count and procalcitonin, and between platelet count and serum urea, both strongly significant in bivariate comparisons, were attenuated to statistical insignificance after adjustment for CRP alone. The platelet-procalcitonin correlation of minus 0.54 fell to minus 0.25, and the platelet-urea correlation of minus 0.65 fell to minus 0.28. In other words, what looked like a link between coagulation and bacterial-type inflammation, or between coagulation and renal function, may largely reflect shared variation driven by the systemic inflammatory response. The authors caution, however, that attenuation in an observational dataset cannot prove confounding. Depending on the true causal structure, adjusting for CRP might remove confounding, strip away part of a mediated pathway, or introduce bias, and a shift from a significant to a non-significant p-value does not itself demonstrate a statistically meaningful change in the underlying association.

The parasitemia story adds a further layer of nuance. Peripheral parasite density correlated with platelet count before adjustment, at a Spearman coefficient of minus 0.37, but after accounting for CRP the association dissolved to minus 0.21 with a p-value of 0.186. This might suggest that inflammation matters more than parasite burden for platelet depletion, but the authors refuse that leap. A single CRP measurement and a peripheral parasitemia percentage are incomplete snapshots of dynamic processes, and the inconclusive result cannot establish that inflammation outweighs parasite load. Similarly, in penalized logistic models of concurrent severe thrombocytopenia, CRP showed a robust odds ratio of 3.57 per standard deviation increase, while the evidence for parasitemia was inconclusive at an odds ratio of 1.16. The wide confidence intervals, particularly for urea, whose interval spanned more than two orders of magnitude, signal near-separation in the data rather than precise effect estimation.

The aminotransferase axis survived adjustment intact, and the authors interpret this as support for retaining an organ-focused reading of liver tests alongside inflammatory context. Prior work has shown that liver enzyme abnormalities in malaria are typically transient, peaking in the days after treatment begins and resolving within weeks, and correlating with inflammatory markers rather than with the specific antimalarial regimen. The median aspartate-to-alanine ratio in the Polish cohort was 1.02, a non-specific value that cannot pinpoint ischemic or any other particular injury mechanism. The persistence of the enzyme co-variation after CRP adjustment suggests that a single inflammatory marker does not fully explain hepatic test dynamics, but it equally does not demonstrate that liver injury is independent of inflammation. The same restraint applies to the renal findings: a CRP-creatinine partial correlation of plus 0.34 reached only nominal significance and failed correction, and the absence of a surviving renal edge may simply reflect limited power in a cohort where only five patients exceeded the creatinine threshold.

The practical message for clinicians and laboratory diagnosticians is one of interpretive discipline rather than new rules. Co-occurring abnormalities in falciparum malaria should prompt integrated assessment of the patient’s clinical status and the evolution of values over time, not the assumption of a direct inter-organ mechanism. Correlation between abnormal results should never be presented as evidence of the anatomical source or cause of injury. The study explicitly does not validate a CRP cut-off, predict deterioration or bleeding, establish monitoring intervals, or show that adding any test improves outcomes, and its odds ratios and apparent c-statistics support no new decision rule. The limitations are substantial: a retrospective single-centre design, only 48 patients, missing values for procalcitonin, urea and parasitemia in the secondary analyses, and no accounting for prior malaria exposure, immune status, symptom duration, comorbidities or coinfections. The results cannot be extended to children, endemic populations or other Plasmodium species. What the study offers instead is a methodological demonstration, hypothesis-generating evidence that partial correlation analysis can separate robust from fragile laboratory associations in a small clinical cohort, and a clear call for prospective, multicentre validation before any of these patterns inform clinical practice. In a disease that still kills roughly 610,000 people a year worldwide, and that continues to arrive in emergency departments across non-endemic Europe with 6,131 confirmed cases reported in the EU in 2022, teaching clinicians to read the laboratory panel as an interconnected, inflammation-saturated system rather than a list of independent organ alarms may prove one of the quiet but consequential lessons of this modest Polish cohort.

Subject of Research: Partial correlation analysis of inflammation and routine laboratory associations in imported falciparum malaria

Article Title: Inflammation and Routine Laboratory Associations in Imported Falciparum Malaria Assessed by Partial Correlation Analysis

Article References: Pikor, D., Cymerys, M., & Paul, M. (2026). Inflammation and Routine Laboratory Associations in Imported Falciparum Malaria Assessed by Partial Correlation Analysis. Acta Parasitologica, 71(5), Article 223. https://doi.org/10.1007/s11686-026-01409-8

Image Credits: AI Generated

DOI: 10.1007/s11686-026-01409-8

Keywords: malaria, Plasmodium falciparum, C-reactive protein, thrombocytopenia, partial correlation, imported malaria, inflammation, liver enzymes, precision matrix, tropical medicine, hematology, biostatistics